How to Buy Traws Pharma Stock
Traws Pharma Inc
Traws Pharma, Inc. , a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer.
Traws Pharma stock last closed at $1.67, up 3.42% from the previous day, and has decreased 81.76% in one year. It has underperformed other stocks in the Biotechnology industry by 0.32 percentage points. Traws Pharma stock is currently +71.65% from its 52-week low of $0.97, and -91.44% from its 52-week high of $19.44.
At the moment, there are 7.06M TRAW shares outstanding. The market value of TRAW is $11.76M. In the past 24 hours, 52,700 TRAW shares were traded.
How to Buy Traws Pharma Stock
Not sure how to invest in Traws Pharma stock? Here's how.
- Decide where to buy Traws Pharma stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you determine where to buy Traws Pharma stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Select your method of payment and add your info.
- Evaluate Traws Pharma stock: The Traws Pharma ticker symbol is TRAW. Is Traws Pharma stock a good investment? Should you buy shares of TRAW? How do TRAW's underlying business fundamentals look? Do top analysts think Traws Pharma is a good buy? Why has TRAW's stock price moved recently? (Hint: Our stock analysis website can help you figure out if TRAW is a good stock to buy).
- Make your TRAW trade: Decide if you will purchase TRAW shares at the current market price or use a limit order to purchase TRAW stock at a given price.
- Get the latest news on your TRAW position: Create a watchlist to key updates about your investment in Traws Pharma stock.
Step 1: Decide where to buy Traws Pharma stock
You need an online brokerage account in order to access the NASDAQ market and buy TRAW stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, you need to fill out some personal info so you are able to buy TRAW today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start your new trading account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've finished signing up on the best stock market app, you need to deposit funds:
Check out the tutorial below to see the process of transferring money into your brokerage account.
Step 4: Evaluate Traws Pharma stock
After you have chosen the best place to buy Traws Pharma stock, it's absolutely critical to research their stock before you buy, so you actually comprehend the risk and upside.
Traws Pharma Metrics
Traws Pharma Due Diligence Score
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on TRAW's stock page.
What is the fair value of TRAW stock?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge TRAW's intrinsic value.
Using relative valuations ratios:
- TRAW could be undervalued based on its P/E ratio of 0.02x, relative to Biotechnology industry P/E ratio of -105.96x
- TRAW could be undervalued based on its P/B ratio of 1.42x, relative to Biotechnology industry P/B ratio of 4.66x
You can do more valuation analysis on TRAW's stock here.
TRAW Financial Health
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the TRAW balance sheet.
- There are more short-term assets than long-term liabilities on the TRAW balance sheet.
- TRAW profit margin has gone up from -15,345.1% to 3,028.2% in the past year.
Failed Financial Due Diligence Checks:
- TRAW has a relatively high debt to equity ratio of 0.89.
- Total TRAW debt is higher than 5 years ago, relative to shareholder equity.
- TRAW has cash burn of 26932000. It does not have enough cash and short-term investments to cover this.
- TRAW has $13.08M in cash and short term investments. This is not enough to cover its annual cash burn of $26.93M.
You can dig deeper into what analysts are projecting on the Traws Pharma stock forecast page.
TRAW Momentum
TRAW Performance Numbers
Last year, TRAW earnings were $87.91M. In the past five year, TRAW's earnings have gone up by -5.62% per year. This was slower than the Biotechnology industry average of 8.91%.
Last year, TRAW revenue was $2.90M. Over the last 5 year, TRAW's revenue has increased by 70.58% per year. This was faster than the Biotechnology industry average of 66.05%.
Dive into TRAW's earnings and revenue performance here.
Latest Insiders Trades at TRAW
In the last year, executives and large shareholders at TRAW have bought more shares than they have sold.
Werner Cautreels, Chief Executive Officer of TRAW, was the latest TRAW insider to buy. They bought $963.48 worth of TRAW stock on Feb 18, 2025.
Research more about who owns TRAW shares here.
Does TRAW provide a stable income stream?
No, Traws Pharma doesn't provide an income stream by paying out dividends.
What do other investors have to say about TRAW?
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Make your TRAW trade
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally sufficient. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular price, use a limit order.
Press the Open Trade button and eToro will execute your order.
If you want additional assistance investing in stocks on eToro, click the how to video below:
Step 6: Get the latest news on your TRAW position
Now that you own some TRAW stock, you'll want to stay up-to-date on your new company.
Start a watchlist to track the latest developments regarding your TRAW stock.
TRAW Feed
How to Buy Stock in Traws Pharma
To reiterate, here are the 6 steps to buy stock in Traws Pharma:
- Decide where to buy Traws Pharma stock
- Create your brokerage account
- Deposit money your investment account
- Evaluate Traws Pharma stock
- Make your TRAW trade
- Get the latest news on your TRAW position
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your investment in Traws Pharma, create a watchlist today.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.